These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29181)

  • 1. Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties.
    Uzan A; Le Fur G; Mitrani N; Kabouche M; Donadieu AM
    Life Sci; 1978 Jul; 23(3):261-73. PubMed ID: 29181
    [No Abstract]   [Full Text] [Related]  

  • 2. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
    Bartholini G
    Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in mesolimbic homovanillic acid content following discrete modulation of striatal dopamine systems [proceedings].
    Costall B; Naylor RJ
    Br J Pharmacol; 1979 May; 66(1):105P-106P. PubMed ID: 454900
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of aminooxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats.
    Kääriäinen I
    Acta Pharmacol Toxicol (Copenh); 1976 Sep; 39(3):393-400. PubMed ID: 989685
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat.
    Wiesel FA; Sedvall G
    Eur J Pharmacol; 1975 Feb; 30(2):364-7. PubMed ID: 236193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain.
    Walsh FX; Stevens TJ; Langlais PJ; Bird ED
    Ann Neurol; 1982 Jul; 12(1):52-5. PubMed ID: 7114818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Jun; 37(2):249-55. PubMed ID: 954808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drugs, neurotransmitters, and schizophrenia.
    Carlsson A
    Am J Psychiatry; 1978 Feb; 135(2):165-73. PubMed ID: 23684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic post synaptic receptors.
    Le Fur G; Burgevin MC; Malgouris C; Uzan A
    Neuropharmacology; 1979 Jul; 18(7):591-4. PubMed ID: 40153
    [No Abstract]   [Full Text] [Related]  

  • 10. The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools.
    Robinson SE; Berney S; Mishra R; Sulser F
    Psychopharmacology (Berl); 1979 Aug; 64(2):141-7. PubMed ID: 40288
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects.
    Waldmeier PC; Maitre L
    Eur J Pharmacol; 1978 Jan; 47(2):191-200. PubMed ID: 23298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of amperozide on uptake and release of [3H]-dopamine in vitro from perfused rat striatal and limbic brain areas.
    Eriksson E; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():45-8. PubMed ID: 2304895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system.
    Andén NE; Stock G
    J Pharm Pharmacol; 1973 Apr; 25(4):346-8. PubMed ID: 4146695
    [No Abstract]   [Full Text] [Related]  

  • 14. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
    Deutch AY; Tam SY; Freeman AS; Bowers MB; Roth RH
    Eur J Pharmacol; 1987 Feb; 134(3):257-64. PubMed ID: 3569414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive changes of the striatal dopamine system induced by repeated administration of neuroleptics and ergot derivatives.
    Bürki HR
    Adv Biochem Psychopharmacol; 1980; 24():65-8. PubMed ID: 6105806
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.
    Price KS; Farley IJ; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1978; 19():293-300. PubMed ID: 696462
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
    Ahtee L; Kaakkola S
    Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro.
    Howard JL; Large BT; Wedley S; Pullar IA
    Life Sci; 1978 Aug; 23(6):599-603. PubMed ID: 29198
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of piribedil and one of its metabolites on the concentration of homovanillic acid in the rat brain.
    Jori A; Cecchetti G; Dolfini E; Monti E; Garattini S
    Eur J Pharmacol; 1974 Jul; 27(2):245-8. PubMed ID: 4851685
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.
    Waldmeier PC
    Experientia; 1980 Sep; 36(9):1092-4. PubMed ID: 6448165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.